Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vopr Virusol ; 62(1): 25-9, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29323843

RESUMEN

The aim of this work was to estimate the efficacy and safety of single intramuscular introduction of specific heterologous immunoglobulin as prophylactic drug against Ebola hemorrhagic fever. Materials and methods. The specific heterologous immunoglobulin was introduced as a special prophylactic drug to 28 patients in epidemic situations, after skin hurt with infectious materials or contact with infectious blood. Clinico-laboratory observation was performed in 24 subjects after single intramuscular introduction of heterologous immunoglobulin Ebola. The samples of blood serum were investigated for immunoglobulin Ebola and antibodies to horse gamma-globulin on the 30th and 60th days after prophylaxis. Results. None of the subjects of the study contracted Ebola fever. There were no anaphylactic reactions after special prophylaxis with specific heterologous immunoglobulin. Among the subjects with normal allergic state 31% responded with local reactions; 13%, with a general reaction (mild case of the serum disease). Almost no reaction was observed in patients with unfavorable allergic state subjected to desensitizing therapy; in the absence of desensitizing therapy, 50% of patients with unfavorable allergic state exhibited local reactions; 17%, mild cases of the serum disease; 33%, moderate cases of the serum disease. In summary, if the tactics of immunoglobulin application was right, the quantity of local allergic reactions was 28%; of wide spread reactions, 6%. Weak serum disease was observed in 11% of the subjects. The prognostic period of resistance to Ebola fever was less than 30 days. Conclusion. The prophylactic use of specific immunoglobulin from horse blood serum against hemorrhagic Ebola fever is effective and relatively safe in patients subjected to desensitizing therapy.


Asunto(s)
Anticuerpos Antivirales/administración & dosificación , Ebolavirus/inmunología , Fiebre Hemorrágica Ebola/prevención & control , Inmunoglobulina G/administración & dosificación , Profilaxis Pre-Exposición/métodos , Adolescente , Adulto , Animales , Anticuerpos Antivirales/efectos adversos , Anticuerpos Antivirales/sangre , Niño , Trazado de Contacto , Desensibilización Inmunológica , Ebolavirus/patogenicidad , Femenino , Fiebre Hemorrágica Ebola/inmunología , Fiebre Hemorrágica Ebola/transmisión , Fiebre Hemorrágica Ebola/virología , Caballos/sangre , Caballos/inmunología , Humanos , Hipersensibilidad/inmunología , Hipersensibilidad/fisiopatología , Inmunización Pasiva , Inmunoglobulina G/efectos adversos , Inmunoglobulina G/sangre , Inyecciones Intramusculares , Masculino , Persona de Mediana Edad , Lesiones por Pinchazo de Aguja/inmunología , Seguridad del Paciente , Resultado del Tratamiento
2.
Vopr Virusol ; 60(1): 46-9, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-26021075

RESUMEN

The goal of this work was to describe methodological approaches to determination of sensitivity and specificity of the enzyme-linked immunosorbent assay kit (ELISA Kit) for detection of the specific anti-Junin virus (JV) antibody. Comparison of ELISA to plaque reduction neutralization test (PRNT) showed direct relationship between antibody titers in the samples of serum of immunized animals, determined by either PRNT or ELISA methods. The obtained results provided an opportunity to form the panels of positive and negative serum samples to determine the sensitivity and specificity of the ELISA Kit. Sensitivity of the ELISA Kit was at least 98% when studying the samples of serum of immunized guinea pigs and rabbits (determined as positive in PRNT). The sensitivity of the ELISA Kit was at least 68% when studying the samples determined by PNRT as uncertain positive. The specificity was 98%. The specificity of the ELISA Kit was 98%.


Asunto(s)
Anticuerpos Antivirales , Fiebre Hemorrágica Americana , Virus Junin/inmunología , Juego de Reactivos para Diagnóstico , Animales , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Ensayo de Inmunoadsorción Enzimática , Cobayas , Fiebre Hemorrágica Americana/sangre , Fiebre Hemorrágica Americana/diagnóstico , Fiebre Hemorrágica Americana/inmunología , Humanos , Conejos , Sensibilidad y Especificidad
3.
Artículo en Ruso | MEDLINE | ID: mdl-23297643

RESUMEN

AIM: Evaluate safety of prophylaxis of viral hemorrhagic fevers by specific heterologous immunoglobulins. MATERIALS AND METHODS: Clinical-laboratory examination of 24 individuals after intramuscular administration of heterologous Ebola immunoglobulin was carried out. Anaphylactogenicity of the immunoglobulins was studied by WD 42-28-8-89 in guinea pigs compared with commercial preparations. RESULTS: Immediate type reactions were not observed. In individuals with normal anamnesis the number of local reactions was 31%, general in the form of lung serum disease - 13%. In individuals with unfavorable anamnesis against the background of desensitization therapy there were almost no reactions; without it local reactions were present in 50%, mild severity serum lung disease - in 17%, medium - in 33%. Immunoglobulins against especially dangerous viral agents by anaphylactogenic properties did not differ from commercial heterologous preparations. CONCLUSION: Application of specific immunoglobulins from horse blood sera (the main means of protection from dangerous and especially dangerous exotic viral infections) with compliance by desensitization principles is relatively safe. Safe level of sensitization properties is characterized by anaphylaxis index up to 3.7 for guinea pigs.


Asunto(s)
Anticuerpos Antivirales/administración & dosificación , Vacunas contra el Virus del Ébola/administración & dosificación , Fiebre Hemorrágica Ebola/prevención & control , Inmunoglobulinas/administración & dosificación , Adulto , Anafilaxia , Animales , Anticuerpos Antivirales/sangre , Vacunas contra el Virus del Ébola/sangre , Ebolavirus/inmunología , Femenino , Cobayas , Fiebre Hemorrágica Ebola/inmunología , Fiebre Hemorrágica Ebola/virología , Caballos , Humanos , Inmunización , Inmunoglobulinas/sangre , Inyecciones Intramusculares , Pulmón , Masculino
4.
Artículo en Ruso | MEDLINE | ID: mdl-21598620

RESUMEN

AIM: Studies of influence of Yersinia pestis fra-operon carriage on morphological properties of Y. pseudotuberculosis recipient strain cells and colonies at different temperature and cultivation time. MATERIALS AND METHODS: Cultures of Y. pseudotuberculosis isogenic variants were grown on solid nutrient medium at 4 - 6, 9 - 11, 26 - 28 and 36 - 38 degrees C. Indirect hemagglutination was used to determine F1 antigen production. Cytorefractometry was used to determine live cell percentage in colonies. Size and dividing cells percentage was evaluated by using phase-contrast microscope "Lyumam-I2". RESULTS: Time period between appearance of micro-colonies and achievement of maximum colony size increased with cultivation temperature decrease. Size of fra+ and fra- variant colony was not significantly different for every temperature regiment used and was significantly lower at the temperature of 36 - 38 degrees C. CONCLUSION: Temperature has a significant influence on population growth, colony size and form.


Asunto(s)
Proteínas Bacterianas/análisis , Yersinia pseudotuberculosis , Recuento de Colonia Microbiana , Pruebas de Hemaglutinación , Viabilidad Microbiana , Operón/genética , Plásmidos , Temperatura , Transformación Genética , Yersinia pestis/genética , Yersinia pestis/crecimiento & desarrollo , Yersinia pseudotuberculosis/genética , Yersinia pseudotuberculosis/crecimiento & desarrollo
5.
Antibiot Khimioter ; 55(3-4): 21-3, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-20695204

RESUMEN

Clinical trials of tabletted pox vaccine revealed development of tonsillitis as a postvaccinal reaction in some volunteers: ulceronecrotic lesions in the tonsils, lymphadenitis, hyperthermia and asthenia. The main cause of the local inflammatory reactions was activation of the host opportunistic microflora including hemolytic streptococci and Staphylococcus aureus. For the treatment of the infectious complications systemic antimicrobials, such as benzylpenicillin, amoxicillin, ampicillin, cefazolin and fluoroquinolones (ciprofloxacin) in combination with the symptomatic therapy were used. The treatment course of 9 days provided complete elimination of the postvaccinal reactions, the specific antibody generation being not affected.


Asunto(s)
Antibacterianos/uso terapéutico , Vacuna contra Viruela/efectos adversos , Tonsilitis/tratamiento farmacológico , Úlcera/tratamiento farmacológico , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Humanos , Necrosis/tratamiento farmacológico , Necrosis/etiología , Tonsila Palatina/efectos de los fármacos , Tonsila Palatina/patología , Vacuna contra Viruela/inmunología , Tonsilitis/etiología , Tonsilitis/patología , Úlcera/etiología , Virus Vaccinia/inmunología
6.
Vopr Virusol ; 55(1): 45-8, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-20364672

RESUMEN

The time course of changes in the activity of solutions of horseradish peroxidase conjugates with immunoglobulins against Ebola and Marburg fevers was studied in the presence of different components. The series of the conjugates of ELISA kits for the detection of Ebola and Marburg virus antigens, which were prepared on the basis of the designed stabilizing solution, preserved at less than 90% of its baseline activity during 10 months at a storage temperature of 2 to 8 degrees C.


Asunto(s)
Antígenos Virales/aislamiento & purificación , Ebolavirus/aislamiento & purificación , Peroxidasa de Rábano Silvestre/química , Enfermedad del Virus de Marburg/diagnóstico , Marburgvirus/aislamiento & purificación , Animales , Antígenos Virales/inmunología , Ebolavirus/inmunología , Estabilidad de Enzimas , Ensayo de Inmunoadsorción Enzimática , Fiebre Hemorrágica Ebola , Inmunoglobulinas/química , Inmunoglobulinas/inmunología , Marburgvirus/inmunología
7.
Mol Gen Mikrobiol Virusol ; (4): 13-8, 2009.
Artículo en Ruso | MEDLINE | ID: mdl-20017359

RESUMEN

The genotyping variety of 5 known anthracis vaccine strains using 18 variable loci of the chromosomal localization taken from a microbe culture collection of 48 Research Institute of Ministry of Defense was revealed in the research. The stability of the VNTR-loci was shown to be inherited from the B. anthracis strains with common origin and an opportunity of their gene-identification application. The gene profile of each analyzed vaccine strain using every 18 polymorphic loci was determined and the amplification products were sequenced. The variation of electrophoretic mobility of the amplifiers was found to be caused by the presence of the replication elements with various numbers of copies in their structure.


Asunto(s)
Vacunas contra el Carbunco/genética , Bacillus anthracis/genética , ADN Bacteriano/genética , Sitios Genéticos , Repeticiones de Minisatélite
8.
Klin Lab Diagn ; (8): 24-7, 2009 Aug.
Artículo en Ruso | MEDLINE | ID: mdl-19827193

RESUMEN

The study of the time course of changes in cell immunological parameters by a magnetic separation technique in human beings during the administration of plague vaccine in relation to the immunological load revealed the higher blood levels of all T lymphocyte subpopulations on day 14 after vaccination. These changes are most typical of a primary vaccinated cohort. The increased frequency of plague vaccine administration and multiple immunizations with live plague, anthrax, and tularemia vaccines produce the time-course of changes in T lymphocyte populations (subpopulations) in response to the regular administration of plague vaccine. A high immunological load in man also promotes a significant reduction in the level of B lymphocytes.


Asunto(s)
Vacuna contra la Peste/inmunología , Peste/prevención & control , Vacunas contra el Carbunco/inmunología , Linfocitos B/inmunología , Vacunas Bacterianas/inmunología , Francisella tularensis/inmunología , Humanos , Inmunidad Celular , Peste/inmunología , Subgrupos de Linfocitos T/inmunología , Linfocitos T/inmunología , Vacunación , Vacunas Atenuadas/inmunología
10.
Vopr Virusol ; 54(4): 42-4, 2009.
Artículo en Ruso | MEDLINE | ID: mdl-19708556

RESUMEN

The use of guinea pigs as a laboratory model was proven to be appropriate in investigating the protective properties of a heterological immunoglobulin against Bolivian hemorrhagic fever at the preclinical stage of the study. A highly pathogenic Machupo virus strain that caused guinea pigs' death with respect with an agent's dose was cultivated. Injection of 1.0 ml of the immunoglobulin provided a 100% protective effect for the guinea pigs infected with the highly pathogenic Machupo virus strain in a dose of 10 LD50.


Asunto(s)
Infecciones por Arenaviridae/terapia , Arenavirus del Nuevo Mundo , Inmunoglobulinas/administración & dosificación , Inmunoglobulinas/inmunología , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta Inmunológica , Evaluación Preclínica de Medicamentos , Cobayas , Inyecciones Intramusculares
11.
Artículo en Ruso | MEDLINE | ID: mdl-19623715

RESUMEN

AIM: Efficacy of modern fluoroquinolones for urgent prophylaxis and treatment of experimental glanders was studied. In experiments on laboratory animals in vivo, it was shown that sparfloxacin, gemifloxacin, levofloxacin and moxifloxacin were highly effective for urgent prophylaxis and treatment of glanders. MATERIALS AND METHODS: Golden hamsters of both sexes, with weight 80 - 100 g, were inoculated with 100 LD50 of 48-hour agar culture of Burkholderia mallei (strain ts-5). Commercial preparations of 2 - 4th generations of fluoroquinolones: sparfloxacin (Sparflo, India), gemifloxacin (Faktiv, Russia), moxifloxacin (Avelox, Germany), pefloxacin (Abactal, Slovenia), levofloxacin (Eleflox, India), lomefloxacin (Lomeflox, India), ofloxacin (Russia). Urgent prophylaxis started 3 hours after inoculation with duration of 10 days, whereas treatment started 24 hours after inoculation with duration of 15 days. Daily dose of pefloxacin, ciprofloxacin, of loxacin was divided on 2 parts, which were administered with 12-hour interval; other drugswere administered once a day. RESULTS: All studied drugs, excluding lomefloxacin, were highly effective for urgent prophylaxis and treatment of experimental glanders and provided 80 - 100% protection. CONCLUSION: Third-fourth generations of fluoroquinolones: sparfloxacin, levofloxacin, moxifloxacin, gemifloxacin were highly effective against agent of glanders in in vivo experiments. They are promising drugs for the development of schemes for urgent prophylaxis and treatment of glanders in humans.


Asunto(s)
Antibacterianos/uso terapéutico , Burkholderia mallei , Fluoroquinolonas/uso terapéutico , Muermo/tratamiento farmacológico , Animales , Compuestos Aza/uso terapéutico , Cricetinae , Femenino , Gemifloxacina , Levofloxacino , Masculino , Mesocricetus , Moxifloxacino , Naftiridinas/uso terapéutico , Ofloxacino/uso terapéutico , Quinolinas/uso terapéutico
12.
Artículo en Ruso | MEDLINE | ID: mdl-18819413

RESUMEN

For the first time, temperate Legionella bacteriophage was isolated from organs of guinea pig infected with Philadelphia 1 strain of Legionella pneumophila. Negative colonies of bactriophage from 1.5 to 2.5 mm in diameter were detected. Central part of them was transparent and surrounded by peripheral zone of partial lysis. Electron microscopy showed that corpuscles of the phage consist from multifaceted elongated head of stretched hexagonal form and short tail. The bacteriophage lyzed bacteria, which cause Legionnaires' disease, and also had certain lytic activity against causative agent of tularemia.


Asunto(s)
Bacteriófagos/fisiología , Legionella pneumophila/virología , Animales , Bacteriólisis , Bacteriófagos/clasificación , Bacteriófagos/aislamiento & purificación , Francisella tularensis/virología , Cobayas
13.
Vopr Virusol ; 53(1): 39-41, 2008.
Artículo en Ruso | MEDLINE | ID: mdl-18318136

RESUMEN

Immunoglobulin (Ig) against Marburg fever (MF) has been obtained from the equine serum. In terms of physicochemical and immunobiological properties, the obtained preparation corresponds to the quality of heterologous commercial immunoglobulins. The application of Marburg virus (MV) Ig with a titer of no less than 1:2048 by the emergency prevention scheme 1-2 hours after intraperitoneal inoculation of guinea pigs with MV in a dose of 20-50 LD50 protected 88-100% of the animals from death. MV Ig is recommended for emergency prevention of human MF.


Asunto(s)
Anticuerpos Antivirales/inmunología , Caballos , Inmunización , Inmunoglobulinas/inmunología , Enfermedad del Virus de Marburg/sangre , Marburgvirus/inmunología , Animales , Anticuerpos Antivirales/sangre , Especificidad de Anticuerpos , Cobayas , Inmunoglobulinas/administración & dosificación , Inmunoglobulinas/sangre , Inyecciones Intraperitoneales , Enfermedad del Virus de Marburg/prevención & control , Ratones , Pruebas de Neutralización , Papio , Conejos , Factores de Tiempo
14.
Antibiot Khimioter ; 52(11-12): 21-4, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-19275053

RESUMEN

Comparative in vitro and in vivo efficacy of new fluoroquinolones with respect to pathogens of tularemia, glanders, melioidosis and anthrax was estimated. It was shown that the strains of the tularemia, glanders, melioidosis and anthrax pathogens were in vitro highly susceptible to the new agents. The experiments on laboratory animals demonstrated that pefloxacin and sparfloxacin had extremely broad spectra and were of special value in emergency prophylaxis of tularemia, glanders, melioidosis and anthrax.


Asunto(s)
Carbunco/tratamiento farmacológico , Antibacterianos/farmacología , Fluoroquinolonas/farmacología , Muermo/tratamiento farmacológico , Melioidosis/tratamiento farmacológico , Tularemia/tratamiento farmacológico , Animales , Carbunco/microbiología , Antibacterianos/uso terapéutico , Bacillus anthracis/efectos de los fármacos , Burkholderia pseudomallei/efectos de los fármacos , Cricetinae , Fluoroquinolonas/uso terapéutico , Francisella tularensis/efectos de los fármacos , Muermo/microbiología , Cobayas , Melioidosis/microbiología , Mesocricetus , Tularemia/microbiología
15.
Vopr Virusol ; 51(5): 8-16, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-17087059
16.
Vopr Virusol ; 48(6): 43-5, 2003.
Artículo en Ruso | MEDLINE | ID: mdl-14708232

RESUMEN

The use of guinea pigs as a laboratory model was proven to be appropriate in investigating the vaccines developed against Lassa fever at the preclinical study stage. An adapted variant of Lassa virus was cultivated, which caused death of guinea pigs with respect for an agent's dose. Finally, it was shown to be possible to investigate the immunogenic and protective properties of the inactivated antigen of Lassa virus in experiments with guinea pigs.


Asunto(s)
Fiebre de Lassa/prevención & control , Vacunas Virales/administración & dosificación , Animales , Antígenos Virales/inmunología , Femenino , Cobayas , Virus Lassa/inmunología , Masculino , Vacunas Virales/inmunología
18.
Ontogenez ; 31(4): 243-50, 2000.
Artículo en Ruso | MEDLINE | ID: mdl-10984899

RESUMEN

In this article we attempt to analyze the relationship between the processes, which occur in the nucleus, and the dynamics of chromatin, as well as to classify the changes in the position of chromatin in the cell nucleus during the lifetime of the cell. The proposed concept integrates possible types of chromatin movement within the nucleus.


Asunto(s)
Núcleo Celular/química , Cromatina/química , Interfase , Animales
19.
Artículo en Ruso | MEDLINE | ID: mdl-10808570

RESUMEN

The results of the molecular biological detection of the etiologic agent of hemorrhagic fever in Rostov Province are presented. The role of the causative agents of Astrakhan rickettsial fever, hemorrhagic fever with the renal syndrome, Q fever, leptospirosis and listeriosis has been excluded by means of such immunochemical reactions as the direct and indirect immunofluorescent tests, the solid-phase immunoenzyme assay, the complement fixation test and the agglutination test. The relationship between the cases of hemorrhagic fever in the focus of the outbreak and Crimean-Congo hemorrhagic fever virus has been demonstrated due to the use of the polymerase chain reaction with preliminary reverse transcription.


Asunto(s)
Brotes de Enfermedades , Virus de la Fiebre Hemorrágica de Crimea-Congo/aislamiento & purificación , Fiebre Hemorrágica de Crimea/diagnóstico , Anticuerpos Antivirales/sangre , Especificidad de Anticuerpos , Secuencia de Bases , Cartilla de ADN , Diagnóstico Diferencial , Virus de la Fiebre Hemorrágica de Crimea-Congo/genética , Virus de la Fiebre Hemorrágica de Crimea-Congo/inmunología , Fiebre Hemorrágica de Crimea/epidemiología , Fiebre Hemorrágica de Crimea/etiología , Humanos , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa/métodos , Federación de Rusia/epidemiología , Pruebas Serológicas/métodos
20.
Artículo en Ruso | MEDLINE | ID: mdl-10808571

RESUMEN

The results of the epidemiological analysis of the outbreak of hemorrhagic fever which was caused by Crimean-Congo hemorrhagic fever virus and occurred during the period of July 3-19, 1999, in the Oblivskaya district of Rostov Province are presented. The specific epidemiological features of the outbreak have been determined. The possible versions of the appearance of the focus of infection and the role of Ixodes ticks in the circulation of the infective agent are discussed.


Asunto(s)
Brotes de Enfermedades , Fiebre Hemorrágica de Crimea/epidemiología , Adolescente , Adulto , Distribución por Edad , Distribución de Chi-Cuadrado , Niño , Preescolar , Brotes de Enfermedades/estadística & datos numéricos , Reservorios de Enfermedades/estadística & datos numéricos , Femenino , Fiebre Hemorrágica de Crimea/diagnóstico , Fiebre Hemorrágica de Crimea/etiología , Fiebre Hemorrágica de Crimea/transmisión , Humanos , Lactante , Masculino , Persona de Mediana Edad , Factores de Riesgo , Federación de Rusia/epidemiología , Distribución por Sexo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...